Jeffrey J Sutherland

Prioritizing hits from phenotypic high-content screens.

Jonathan Low, Louis Stancato, Jonathan Lee, 2008, Current opinion in drug discovery & development.

A Novel Open Access Web Portal for Integrating Mechanistic and Toxicogenomic Study Results

Jeffrey J Sutherland, Navin Elango, Kamin J. Johnson, 2019, Toxicological sciences : an official journal of the Society of Toxicology.

A Robust High-Content Imaging Approach for Probing the Mechanism of Action and Phenotypic Outcomes of Cell-Cycle Modulators

Jonathan Low, Jeffrey J Sutherland, J. Sutherland, 2011, Molecular Cancer Therapeutics.

Dependence of molecular properties on proteomic family for marketed oral drugs.

Michal Vieth, Jeffrey J Sutherland, M. Vieth, 2006, Journal of medicinal chemistry.

Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes.

Jeffrey J Sutherland, John W Raymond, James L Stevens, 2012, Journal of medicinal chemistry.

What general conclusions can we draw from kinase profiling data sets?

Michal Vieth, Cen Gao, Jeffrey J Sutherland, 2013, Biochimica et biophysica acta.